scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Long term survival of vascular accesses in a large chronic hemodialysis population

01 Jan 1995-Nephron (NEPHRON)-Vol. 69, Iss: 3, pp 228-233
TL;DR: Long-term patency of access was evaluated in 76 patients, without diabetes mellitus, who had been on dialysis for at least 3 years and 41 patients, with diabetes mell Titus, whoHad been ondialysis for over 2 years, finding fistulas functioned longer than grafts and declotting or revision of restored graft function was ineffective.
Abstract: Complications associated with vascular accesses account for approximately 30% of hospital admissions for chronic hemodialysis patients. Long-term patency of access was evaluated in 76 patients, without diabetes mellitus, who had been on dialysis for at least 3 years and 41 patients, with diabetes mellitus, who had been on dialysis for over 2 years. Fistulas functioned longer than grafts (58 vs. 22 months, p
Citations
More filters
Journal ArticleDOI
TL;DR: Large differences in vascular access use exist between EUR and the US, even after adjustment for patient characteristics, and the results strongly suggest that a facility's preferences and approaches to vascular access practice are major determinants of vascularAccess use.

820 citations

Journal ArticleDOI
TL;DR: Type of initial hemodialysis access was associated with 1-year mortality in the US Medicare dialysis population and Mortality risks were fistulae, grafts, and catheters.

327 citations

Journal ArticleDOI
TL;DR: Results show that the upper-arm native arteriovenous fistula (UAF) is a good alternative to an AVG for achieving Dialysis Outcomes Quality Initiative guidelines.

269 citations

Journal ArticleDOI
TL;DR: A program for early placement of A-V fistulae, a continuous quality improvement, multidisciplinary program to monitor access outcome, the development of new biomaterials, and a research plan to investigate pharmacological intervention to reduce development of stenosis and clinical interventions to treat those that do develop, prior to thrombosis are proposed.

267 citations


Additional excerpts

  • ...is small and declining [64–68]....

    [...]

Journal ArticleDOI
TL;DR: The patency rate for PTFEs is similar to that for AVFs, but AVFs require fewer revisions, and AVFs have excellent patency rates and PDCs have excellentPatency rates, but failure rates are doubled in patients with diabetes.

264 citations